CBT Treatment for Internet Gaming Disorder (IGD RCT)

May 13, 2025 updated by: Anna Gordh, Sahlgrenska University Hospital

Gaming Disorder- a Randomized Controlled Trial in a Clinical Setting

For most people, gaming is perceived as a positive activity. In some cases, however, gaming may turn into an addiction with consequences for the individual health, quality of life and everyday life. Today, there is a lack of evidence-based interventions to treat this condition, called Gaming Disorder (GD). This study will evaluate a new manual for treatment of GD, divided into a number of modules and based on cognitive behavioural therapy (CBT). The study is designed as a randomized controlled trial (RCT) and will be conducted at a clinic specialized in the treatment of gambling and gaming addiction.

Participants included in the study will be randomized to one of to groups. The intervention group will receive twelve weeks of individual CBT-treatment while participants allocated to the control group will be put on a twelve-week wait-list.

The hypothesis is that the manual based CBT treatment will result in a greater reduction in symptoms of criteria for GD.

Study Overview

Detailed Description

The study is designed as a two-armed randomized controlled trial. After inclusion, every participant will be offered an overview of the participant´s psychosocial circumstances. Thereafter, the participants will be randomized to one of the two arms.

The main arm includes individual CBT treatment following a module-based manual. The manual includes nine main modules and three optional modules addressing different dimensions of gaming disorder, for example thoughts, emotions, and procrastination. Between every session the participants are working with home assignments, in order to strengthen helpful behaviours. The participants also report amount of time spent on gaming and other activities every week.

Participants randomized to the control arm also report their time spent on gaming and other activities every week.The wait-list control has the same duration as the CBT-arm. After the control-period, participants in the control arm will be offered the same treatment as participants in the intervention arm.

Study Type

Interventional

Enrollment (Estimated)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Gothenburg, Sweden
        • Clinic for gambling addiction and screen health
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Fulfilling 5 out of 9 criteria for IGD according to DSM V
  • ≥ 16 years of age
  • Can read and speak Swedish fluidly.

Exclusion Criteria:

  • Somatic or psychiatric disease that is contraindicating or severely complicates the implementation of the intervention (e.g., ongoing psychotic, manic or hypomanic episode or neuropsychiatric condition with severe disability)
  • Ongoing increased suicide risk that is considered to make it inappropriate for the patient to participate in the study (based on evaluation at the structured clinical interview)
  • have another ongoing psychological treatment with a content similar to that in the current study
  • plan to start such treatment during the XX weeks that the study is ongoing or has during the last three weeks started or changed medication for any psychiatric problem.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CBT treatment

The CBT-arm includes treatment according to a manual developed to treat GD. The manual is based on nine main and three optional modules. Each module covers different topics identified as problematic for individuals with GD, for example "thoughts" and "feelings". It is possible to adjust the number of modules, in line with the individual plan for every participant.

During the treatment period, the participants report their weekly time spent on gaming, non-gaming screen-time and on other activities.

Cognitive Behavioral Treatment for Gaming Disorder.
Other: Wait list control
Participants randomised to the control-arm is put on a twelve-week wait-list. During this time, the participants will report their weekly time spent on gaming, non-gaming screen-time and on other activities.
No intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Internet Gaming Disorder Scale- Short Form (IGDS9-SF)
Time Frame: Up to 24 weeks.
Change in number of diagnostic criteria of Internet Gaming Disorder according to DSM-5. The score ranges from 9 to 45. A higher score indicates more problems related to gaming.
Up to 24 weeks.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Timeline follow back for gaming (TLFB-GD)
Time Frame: Up to 12 weeks.
Registration of time spent on gaming and other activities during the twelve weeks of treatment.
Up to 12 weeks.
Gaming Disorder Test (GDT)
Time Frame: Up to 24 weeks.
Measures symptoms of GD according to ICD-10. A higher score indiciate a higher risk of GD.
Up to 24 weeks.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient health´s questionnaire (PHQ-9)
Time Frame: Up to 24 weeks.
Measure of symptoms of depression. The total score is ranging from 0 to 27, with higher scores indicating more severe depressive symptoms.
Up to 24 weeks.
Generalized Anxiety Disorder (GAD-7)
Time Frame: Up to 24 weeks.
Measures symptoms of anxiety. The total score is 21, with cut off points at 5, 10 and 15, indicating minimal (0-4), mild (5-9), moderate (10-14) and severe (15-21) levels of anxiety. Higher scores indicate more severe anxiety.
Up to 24 weeks.
Brunnsviken Brief Quality of life scale (BBQ)
Time Frame: Up to 24 weeks.
Questionnaire for quality of life. The possible total score is 96 with higher scores indicating higher perceived quality of life.
Up to 24 weeks.
Physical activity
Time Frame: Up to 24 weeks.
Assessment of the level of physical activity and sedentary behavior. A low level of physical activity and a high amount of sedentary time is increasing the risk of several life-style related diseases.
Up to 24 weeks.
Motives for Online Gaming Questionnaire (MOGQ)
Time Frame: Up to 24 weeks.
Self-report instrument for measuring motives for gaming. It covers seven different motives for gaming. A higher score suggests several motives for individual gaming.
Up to 24 weeks.
Alcohol Use Disorders Identification Test (AUDIT)
Time Frame: Up to 24 weeks.
This instrument is used to identify inidividuals with harmful use of alcohol. A score higher than 6 indicate problematic use of alcohol.
Up to 24 weeks.
Drug Use Disorders Identification Test (DUDIT)
Time Frame: Up to 24 weeks.
A screening tool for the use of drugs and events of drug-related consequences. A higher score indicate higher use of drugs.
Up to 24 weeks.
Family APGAR
Time Frame: Up to 12 weeks.
The purpose of the Family APGAR is to qualitatively measure five components of family functioning: "adaptation", "partnership", "growth", "affection" and "resolve".
Up to 12 weeks.
Negative Effects Questionnaire (NEQ)
Time Frame: After treatment completion (up to 12 weeks).
The purpose of the NEQ is to measure negative or adverse effects of psychological treatment, as experienced by the patient. Lower scores indiciate less negative effects of the psychological treatment.
After treatment completion (up to 12 weeks).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anna Gordh, Ass. Prof, Mottagning för spelberoende och skärmhälsa

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 1, 2025

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Study Registration Dates

First Submitted

March 9, 2022

First Submitted That Met QC Criteria

April 6, 2022

First Posted (Actual)

April 14, 2022

Study Record Updates

Last Update Posted (Actual)

May 16, 2025

Last Update Submitted That Met QC Criteria

May 13, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

After publication of data the IPD will be available at request.

IPD Sharing Time Frame

After publication of data.

IPD Sharing Access Criteria

Not decided yet.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Internet Gaming Disorder

Clinical Trials on Wait list control

Subscribe